Leptin Protein (26-006897)
Key Takeaways
- Set-aside for No Set Aside businesses
- Work to be performed in BETHESDA, MD
- Industry: Biological Product (except Diagnostic) Manufacturing
Contract Details
- Notice ID
- 26-006897
- Opportunity Type
- Special Notice
- Sub-Agency
- NATIONAL INSTITUTES OF HEALTH
- Office
- NATIONAL INSTITUTES OF HEALTH OLAO
- Posted Date
- Wednesday, August 19, 2026
- Response Deadline
- Wednesday, August 26, 2026
- PSC Code
- 6505
- Set-Aside
- No Set Aside
- Place of Performance
- BETHESDA, MD, 20892
- Status
- Active
Description
The National Institute of Health (NIH) intends to negotiate and award a purchase order without providing for full and open competition to BIO-TECHNE SALES CORP. The purpose of this requirement is to provide a firm-fixed-price contract for Recombinant Rat Leptin Protein in the Critical Care Medicine Department within the NIH Clinical Center. The Critical Care Medicine Department conducts active research programs in bedside clinical investigation, research in animal models, and molecular biology. Full-time research activities commence at the beginning of the second year of the fellowship for fellows interested in the critical care subspecialty alone. For those interested in dual board eligibility, their second-year program is individually designed and consists of clinical rotations required
Why This Opportunity Matters
HEALTH AND HUMAN SERVICES, DEPARTMENT OF is seeking responses for biological product (except diagnostic) manufacturing with a set-aside for No Set Aside businesses in BETHESDA, MD. This set-aside designation means eligible businesses face reduced competition from larger firms.
Similar Opportunities
Browse Related
Looking for more opportunities?
Browse our full directory of government contracts